BUPROPION HYDROCHLORIDE (XL)

BUPROPION HYDROCHLORIDE (XL) was reported 2798 times

BUPROPION HYDROCHLORIDE (XL) is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 COELIAC ARTERY COMPRESSION SYNDROME 2 0.0267
1 BINGE DRINKING 3 0.0265
2 SEXUAL ACTIVITY INCREASED 2 0.0168
3 VESSEL PUNCTURE SITE BRUISE 3 0.0151
4 URINE AMPHETAMINE POSITIVE 4 0.0122
5 FIBROMUSCULAR DYSPLASIA 2 0.0122
6 ANAL SKIN TAGS 2 0.0121
7 MANIC SYMPTOM 2 0.0119
8 SYMPATHOMIMETIC EFFECT 2 0.0087
9 MANUFACTURING MATERIALS ISSUE 3 0.0074
10 CERVICITIS 3 0.0067
11 ACROMEGALY 2 0.0063
12 MEDICATION RESIDUE PRESENT 30 0.0063
13 HELPLESSNESS 3 0.0063
14 OESOPHAGEAL ACHALASIA 4 0.0062
15 IMMUNODEFICIENCY COMMON VARIABLE 3 0.0061
16 ARRHYTHMIC STORM 2 0.0060
17 BOREDOM 2 0.0059
18 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 29 0.0057
19 ABDOMINAL STRANGULATED HERNIA 1 0.0055
20 GRANDIOSITY 2 0.0055
21 THOUGHT BLOCKING 3 0.0051
22 ANHIDROSIS 2 0.0049
23 PRODUCT SUBSTITUTION ISSUE 282 0.0049
24 RED BLOOD CELL TRANSFUSION 2 0.0049
25 PUPIL FIXED 8 0.0046
26 FEELINGS OF WORTHLESSNESS 6 0.0046
27 TEMPORAL LOBE EPILEPSY 2 0.0046
28 HALLUCINATION, TACTILE 3 0.0045
29 ALLERGY TO PLANTS 2 0.0044
30 MANUFACTURING ISSUE 2 0.0043
31 SJS-TEN OVERLAP 3 0.0043
32 SLEEP-RELATED EATING DISORDER 4 0.0043
33 SUSPECTED SUICIDE 20 0.0043
34 ACCIDENTAL EXPOSURE TO PRODUCT PACKAGING 1 0.0042
35 SLEEP ATTACKS 2 0.0042
36 PRODUCT ADMINISTRATION INTERRUPTED 33 0.0042
37 PRODUCT RESIDUE PRESENT 20 0.0037
38 WHITE COAT HYPERTENSION 2 0.0037
39 MORNING SICKNESS 2 0.0037
40 DISTRACTIBILITY 4 0.0035
41 MENTAL DISABILITY 2 0.0035
42 ABSCESS DRAINAGE 3 0.0035
43 PRE-EXISTING CONDITION IMPROVED 21 0.0034
44 TOOTH EROSION 4 0.0033
45 INFUSION SITE IRRITATION 4 0.0031
46 FALSE POSITIVE INVESTIGATION RESULT 3 0.0030
47 PRODUCT SOLUBILITY ABNORMAL 15 0.0030
48 INFUSION SITE DISCOMFORT 3 0.0029
49 WRONG DOSE 7 0.0029
50 OBSTRUCTIVE SLEEP APNOEA SYNDROME 4 0.0027
51 TEMPERATURE REGULATION DISORDER 6 0.0027
52 FOREIGN BODY IN UROGENITAL TRACT 2 0.0026
53 LABORATORY TEST INTERFERENCE 2 0.0025
54 RETINAL PIGMENTATION 2 0.0025
55 CARDIOGENIC SHOCK 36 0.0025
56 POST-ACUTE COVID-19 SYNDROME 3 0.0024
57 SLEEP TALKING 4 0.0024
58 INTENTIONAL DEVICE USE ISSUE 2 0.0023
59 CORONARY ARTERY DISSECTION 2 0.0023
60 DRUG TITRATION ERROR 6 0.0023
61 INTESTINAL PSEUDO-OBSTRUCTION 2 0.0023
62 DISTRIBUTIVE SHOCK 5 0.0022
63 NEONATAL RESPIRATORY DISTRESS 2 0.0021
64 SKIN TEXTURE ABNORMAL 2 0.0021
65 SLEEP PARALYSIS 3 0.0020
66 GENERALISED ANXIETY DISORDER 3 0.0020
67 SUSPECTED PRODUCT CONTAMINATION 2 0.0020
68 STATUS EPILEPTICUS 22 0.0019
69 POSTICTAL STATE 2 0.0019
70 SUBSTANCE USE 3 0.0019
71 PRODUCT COMMINGLING 2 0.0019
72 AREFLEXIA 5 0.0019
73 IMPULSIVE BEHAVIOUR 7 0.0019
74 BIPOLAR I DISORDER 4 0.0018
75 GENERALISED TONIC-CLONIC SEIZURE 30 0.0018
76 MEDICAL PROCEDURE 3 0.0018
77 CORTISOL DECREASED 2 0.0017
78 ENURESIS 7 0.0017
79 COELIAC DISEASE 17 0.0017
80 SPINAL CORD INJURY 3 0.0017
81 INTRUSIVE THOUGHTS 2 0.0017
82 TERMINAL INSOMNIA 3 0.0017
83 FOOD ALLERGY 13 0.0017
84 FULL BLOOD COUNT INCREASED 2 0.0017
85 OXYGEN CONSUMPTION INCREASED 4 0.0017
86 PRODUCT FORMULATION ISSUE 11 0.0017
87 RECTAL PROLAPSE 2 0.0017
88 INFUSION SITE WARMTH 2 0.0016
89 STERNAL FRACTURE 2 0.0016
90 BLADDER DISCOMFORT 2 0.0016
91 BREECH PRESENTATION 2 0.0016
92 EXPOSURE VIA INGESTION 4 0.0016
93 HYPOREFLEXIA 3 0.0016
94 PATIENT DISSATISFACTION WITH TREATMENT 3 0.0016
95 GESTATIONAL HYPERTENSION 2 0.0015
96 ADJUSTMENT DISORDER 2 0.0015
97 LIBIDO DISORDER 2 0.0015
98 STOMA SITE INFECTION 2 0.0015
99 PROTEIN TOTAL ABNORMAL 2 0.0015
100 PRODUCT ODOUR ABNORMAL 16 0.0015
101 BREAST ENLARGEMENT 5 0.0015
102 LYMPHOCYTE PERCENTAGE DECREASED 2 0.0015
103 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 2 0.0015
104 CLUSTER HEADACHE 2 0.0015
105 APPLICATION SITE INFLAMMATION 2 0.0014
106 DEPRESSION SUICIDAL 5 0.0014
107 TACHYPHRENIA 5 0.0014
108 PULSELESS ELECTRICAL ACTIVITY 6 0.0014
109 ECHOCARDIOGRAM ABNORMAL 2 0.0014
110 DEVICE CONNECTION ISSUE 3 0.0014
111 THERAPEUTIC RESPONSE CHANGED 9 0.0014
112 CATAPLEXY 2 0.0014
113 BLOOD ELECTROLYTES DECREASED 2 0.0014
114 JUDGEMENT IMPAIRED 2 0.0014
115 SYMPTOM RECURRENCE 8 0.0013
116 COMPLETED SUICIDE 111 0.0013
117 HEAT STROKE 2 0.0013
118 INSURANCE ISSUE 20 0.0013
119 INFUSION SITE INFECTION 3 0.0013
120 POLYCYSTIC OVARIES 2 0.0013
121 INTENTIONAL OVERDOSE 81 0.0013
122 GESTATIONAL DIABETES 6 0.0013
123 TOTAL LUNG CAPACITY DECREASED 2 0.0013
124 ACNE PUSTULAR 1 0.0012
125 INFUSION SITE HAEMORRHAGE 4 0.0012
126 DEVICE INFUSION ISSUE 3 0.0012
127 PERSECUTORY DELUSION 3 0.0012
128 VEIN RUPTURE 2 0.0012
129 BUNDLE BRANCH BLOCK LEFT 5 0.0012
130 EXPOSURE TO SARS-COV-2 2 0.0012
131 TEARFULNESS 5 0.0012
132 FIXED ERUPTION 2 0.0012
133 CRYING 42 0.0012
134 MUSCLE CONTRACTIONS INVOLUNTARY 4 0.0011
135 ABDOMINAL SEPSIS 1 0.0011
136 MACULOPATHY 4 0.0011
137 ANIMAL BITE 3 0.0011
138 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 2 0.0011
139 INFUSION SITE SWELLING 7 0.0011
140 MAJOR DEPRESSION 8 0.0011
141 SEROTONIN SYNDROME 21 0.0011
142 ABULIA 1 0.0011
143 PUPILLARY REFLEX IMPAIRED 2 0.0011
144 CARDIO-RESPIRATORY ARREST 45 0.0011
145 TRICHORRHEXIS 3 0.0011
146 ELECTRIC SHOCK SENSATION 3 0.0011
147 BONE DENSITY ABNORMAL 4 0.0011
148 SOMNAMBULISM 7 0.0011
149 IMPATIENCE 2 0.0011
150 TRAUMATIC LUNG INJURY 2 0.0010
151 CONVERSION DISORDER 2 0.0010
152 VENTRICULAR TACHYCARDIA 17 0.0010
153 NASAL SEPTUM DEVIATION 2 0.0010
154 MIDDLE INSOMNIA 19 0.0010
155 DRUG DELIVERY SYSTEM ISSUE 2 0.0010
156 IMMUNODEFICIENCY 15 0.0010
157 FORMICATION 7 0.0010
158 SUICIDAL IDEATION 92 0.0010
159 ALLERGIC REACTION TO EXCIPIENT 2 0.0010
160 HYPERPHAGIA 4 0.0010
161 ACNE CYSTIC 3 0.0010
162 MUCOSAL DRYNESS 2 0.0010
163 EUPHORIC MOOD 10 0.0010
164 TONGUE BITING 2 0.0010
165 SPINAL STENOSIS 4 0.0010
166 FOETAL DEATH 5 0.0010
167 EYE CONTUSION 2 0.0009
168 BRUXISM 5 0.0009
169 INFUSION SITE BRUISING 2 0.0009
170 MYOCLONUS 11 0.0009
171 TINNITUS 42 0.0009
172 DYSPHEMIA 4 0.0009
173 INABILITY TO AFFORD MEDICATION 9 0.0009
174 BRAIN FOG 14 0.0009
175 RENAL COLIC 2 0.0009
176 WOUND COMPLICATION 3 0.0009
177 BUNDLE BRANCH BLOCK RIGHT 4 0.0009
178 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 2 0.0009
179 REACTION TO EXCIPIENT 2 0.0009
180 HYPERREFLEXIA 3 0.0009
181 FEELING OF DESPAIR 4 0.0009
182 SINUS PAIN 2 0.0009
183 SUICIDE ATTEMPT 52 0.0009
184 FEELING OF BODY TEMPERATURE CHANGE 5 0.0009
185 UPPER-AIRWAY COUGH SYNDROME 7 0.0008
186 SINUS TACHYCARDIA 12 0.0008
187 URINE FLOW DECREASED 2 0.0008
188 INFUSION SITE ERYTHEMA 7 0.0008
189 DEPRESSION 188 0.0008
190 SELF ESTEEM DECREASED 2 0.0008
191 PANIC ATTACK 30 0.0008
192 INTENTIONAL DOSE OMISSION 23 0.0008
193 ELECTROCARDIOGRAM QT PROLONGED 29 0.0008
194 CARDIAC DYSFUNCTION 3 0.0008
195 IRRITABILITY 48 0.0008
196 PAROSMIA 6 0.0008
197 SNORING 3 0.0008
198 AUTOIMMUNE THYROIDITIS 3 0.0008
199 MENTAL STATUS CHANGES 22 0.0008
200 FEELING JITTERY 15 0.0008
201 SEDATION COMPLICATION 2 0.0008
202 PHLEBITIS 4 0.0008
203 ABNORMAL UTERINE BLEEDING 2 0.0008
204 SEASONAL ALLERGY 11 0.0008
205 INFUSION SITE PAIN 10 0.0008
206 CATHETER SITE PAIN 2 0.0008
207 CARDIOPULMONARY FAILURE 3 0.0008
208 MULTIPLE ALLERGIES 6 0.0008
209 WITHDRAWAL SYNDROME 32 0.0008
210 RADICULOPATHY 2 0.0008
211 BREAST MASS 5 0.0007
212 CHONDROPATHY 2 0.0007
213 PERIPHERAL VENOUS DISEASE 3 0.0007
214 TRIGGER FINGER 3 0.0007
215 CLUMSINESS 2 0.0007
216 CLONUS 2 0.0007
217 ABSCESS ORAL 1 0.0007
218 ECONOMIC PROBLEM 11 0.0007
219 DRUG SCREEN FALSE POSITIVE 2 0.0007
220 SELF-INJURIOUS IDEATION 3 0.0007
221 DISEASE RECURRENCE 34 0.0007
222 PRODUCT LEAKAGE 4 0.0007
223 ATTENTION DEFICIT HYPERACTIVITY DISORDER 3 0.0007
224 BREAST CANCER STAGE IV 2 0.0007
225 IMPAIRED QUALITY OF LIFE 10 0.0007
226 UPPER RESPIRATORY TRACT CONGESTION 2 0.0007
227 DYSPNOEA AT REST 2 0.0007
228 COMA SCALE ABNORMAL 2 0.0007
229 MELANOCYTIC NAEVUS 3 0.0007
230 INITIAL INSOMNIA 7 0.0007
231 NECK INJURY 2 0.0007
232 DECREASED INTEREST 4 0.0007
233 CARDIOTOXICITY 6 0.0007
234 FOREIGN BODY IN REPRODUCTIVE TRACT 6 0.0007
235 PRODUCT QUALITY ISSUE 91 0.0007
236 BRAIN HERNIATION 2 0.0007
237 MANIA 11 0.0007
238 DISTURBANCE IN ATTENTION 36 0.0007
239 ANAL INCONTINENCE 6 0.0007
240 CRANIOCEREBRAL INJURY 2 0.0007
241 IMPAIRED GASTRIC EMPTYING 9 0.0007
242 SEIZURE 76 0.0007
243 CHEST X-RAY ABNORMAL 2 0.0007
244 ENCEPHALOPATHY 16 0.0007
245 ANGER 22 0.0006
246 SPINAL OPERATION 8 0.0006
247 SURGERY 38 0.0006
248 BRAIN DEATH 2 0.0006
249 THINKING ABNORMAL 12 0.0006
250 SKIN ABRASION 3 0.0006
251 MOOD SWINGS 20 0.0006
252 MYDRIASIS 8 0.0006
253 VENTRICULAR HYPOKINESIA 2 0.0006
254 PRESCRIBED OVERDOSE 12 0.0006
255 FRUSTRATION TOLERANCE DECREASED 5 0.0006
256 APATHY 9 0.0006
257 HYPERNATRAEMIA 3 0.0006
258 HYPOTONIA 6 0.0006
259 POST-TRAUMATIC STRESS DISORDER 4 0.0006
260 CERVICAL VERTEBRAL FRACTURE 2 0.0006
261 BLOOD CREATININE ABNORMAL 2 0.0006
262 BURSITIS 7 0.0006
263 SLEEP APNOEA SYNDROME 11 0.0006
264 ANXIETY 164 0.0006
265 HUNGER 8 0.0006
266 AGITATION 42 0.0006
267 HAND FRACTURE 4 0.0006
268 HAEMORRHAGIC DIATHESIS 2 0.0006
269 IMPAIRED WORK ABILITY 12 0.0006
270 GASTROINTESTINAL MOTILITY DISORDER 3 0.0006
271 COMPRESSION FRACTURE 3 0.0006
272 ANAL FISSURE 3 0.0006
273 STRESS FRACTURE 3 0.0006
274 HYPOKINESIA 8 0.0006
275 VENTRICULAR ARRHYTHMIA 2 0.0005
276 PRODUCT PHYSICAL ISSUE 11 0.0005
277 DEAFNESS UNILATERAL 3 0.0005
278 PSYCHOMOTOR HYPERACTIVITY 9 0.0005
279 HYPERACUSIS 2 0.0005
280 CHRONIC SINUSITIS 2 0.0005
281 ANHEDONIA 14 0.0005
282 PARANASAL SINUS DISCOMFORT 2 0.0005
283 IMPAIRED DRIVING ABILITY 6 0.0005
284 PARANASAL SINUS HYPERSECRETION 2 0.0005
285 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 2 0.0005
286 HALLUCINATION, VISUAL 11 0.0005
287 GINGIVAL DISORDER 2 0.0005
288 MOUTH SWELLING 3 0.0005
289 CONCUSSION 4 0.0005
290 OPTIC ISCHAEMIC NEUROPATHY 2 0.0005
291 THERAPEUTIC PRODUCT EFFECT VARIABLE 2 0.0005
292 RHINOVIRUS INFECTION 2 0.0005
293 PHARYNGEAL SWELLING 5 0.0005
294 RESPIRATORY ACIDOSIS 2 0.0005
295 THERAPY CHANGE 5 0.0005
296 ENERGY INCREASED 3 0.0005
297 KNEE OPERATION 5 0.0005
298 SUSPECTED COUNTERFEIT PRODUCT 2 0.0005
299 EMBEDDED DEVICE 5 0.0005
300 UNRESPONSIVE TO STIMULI 13 0.0005
301 UPPER RESPIRATORY TRACT INFECTION 23 0.0005
302 NOCTURIA 6 0.0005
303 APPLICATION SITE DISCOLOURATION 2 0.0005
304 DEPRESSED MOOD 26 0.0005
305 INTENTIONAL PRODUCT USE ISSUE 43 0.0005
306 AORTIC DISSECTION 2 0.0005
307 ILEUS 6 0.0005
308 MOOD ALTERED 13 0.0005
309 BLEPHAROSPASM 3 0.0005
310 HALLUCINATIONS, MIXED 2 0.0005
311 SLEEP TERROR 2 0.0005
312 POOR QUALITY PRODUCT ADMINISTERED 5 0.0005
313 CARDIOMYOPATHY 7 0.0005
314 DRUG EFFECT LESS THAN EXPECTED 7 0.0005
315 CARDIAC ARREST 39 0.0005
316 UTERINE HAEMORRHAGE 2 0.0005
317 ABSCESS LIMB 2 0.0005
318 LUNG NEOPLASM 2 0.0005
319 VITAMIN D DECREASED 4 0.0005
320 ADVERSE DRUG REACTION 42 0.0005
321 ROTATOR CUFF SYNDROME 6 0.0005
322 TENSION HEADACHE 2 0.0005
323 POOR QUALITY SLEEP 10 0.0005
324 HEPATIC LESION 2 0.0005
325 OSTEOPENIA 7 0.0005
326 BACK INJURY 5 0.0005
327 RESPIRATORY SYNCYTIAL VIRUS INFECTION 4 0.0005
328 PRODUCT DOSE OMISSION IN ERROR 13 0.0005
329 DIVERTICULUM INTESTINAL 2 0.0005
330 BEDRIDDEN 6 0.0005
331 DYSGRAPHIA 3 0.0005
332 APPETITE DISORDER 3 0.0005
333 ADVERSE REACTION 6 0.0005
334 DENTAL CARIES 5 0.0005
335 HYPERHIDROSIS 58 0.0004
336 HEAVY MENSTRUAL BLEEDING 4 0.0004
337 COVID-19 78 0.0004
338 URINARY TRACT DISORDER 2 0.0004
339 SINUS CONGESTION 6 0.0004
340 COMPLICATION OF DEVICE REMOVAL 8 0.0004
341 PRODUCT LABEL ISSUE 3 0.0004
342 LEUKOCYTOSIS 8 0.0004
343 DRUG EFFECT DELAYED 2 0.0004
344 MIGRAINE 42 0.0004
345 RESTLESS LEGS SYNDROME 8 0.0004
346 URINE ABNORMALITY 2 0.0004
347 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 21 0.0004
348 ILLNESS 45 0.0004
349 DYSPAREUNIA 2 0.0004
350 ABNORMAL DREAMS 12 0.0004
351 NIGHTMARE 15 0.0004
352 HAIR GROWTH ABNORMAL 3 0.0004
353 LARGE INTESTINE POLYP 3 0.0004
354 RENAL FUNCTION TEST ABNORMAL 2 0.0004
355 CONTRAINDICATED PRODUCT ADMINISTERED 13 0.0004
356 PERFORMANCE STATUS DECREASED 2 0.0004
357 UMBILICAL HERNIA 2 0.0004
358 KNEE ARTHROPLASTY 9 0.0004
359 DEVICE OCCLUSION 6 0.0004
360 COLITIS MICROSCOPIC 2 0.0004
361 HYPERSOMNIA 12 0.0004
362 AFFECT LABILITY 4 0.0004
363 VISUAL FIELD DEFECT 3 0.0004
364 DIZZINESS POSTURAL 4 0.0004
365 VITAMIN D DEFICIENCY 4 0.0004
366 TREMOR 68 0.0004
367 ORAL DISORDER 3 0.0004
368 FEELING ABNORMAL 98 0.0004
369 DECREASED IMMUNE RESPONSIVENESS 4 0.0004
370 INSOMNIA 108 0.0004
371 ARTHROPOD BITE 3 0.0004
372 FOOT OPERATION 2 0.0004
373 SALIVARY HYPERSECRETION 4 0.0004
374 POISONING 5 0.0004
375 DYSPHORIA 2 0.0004
376 HYPOTHERMIA 4 0.0004
377 TOXIC ENCEPHALOPATHY 2 0.0004
378 FEEDING DISORDER 8 0.0004
379 HAEMODYNAMIC INSTABILITY 3 0.0004
380 DRY THROAT 4 0.0004
381 APHTHOUS ULCER 3 0.0004
382 APNOEA 3 0.0004
383 ACTINIC KERATOSIS 1 0.0004
384 SLEEP DISORDER 27 0.0004
385 RESTLESSNESS 14 0.0004
386 TORSADE DE POINTES 3 0.0004
387 ELECTROCARDIOGRAM ABNORMAL 3 0.0004
388 AFFECTIVE DISORDER 3 0.0004
389 FOOD CRAVING 2 0.0004
390 BLOOD LACTIC ACID INCREASED 2 0.0004
391 DRUG SCREEN POSITIVE 3 0.0004
392 INCONTINENCE 4 0.0004
393 THERAPY NON-RESPONDER 17 0.0004
394 EAR INFECTION 10 0.0004
395 PSYCHOTIC DISORDER 11 0.0004
396 RHINITIS 3 0.0004
397 DECREASED ACTIVITY 4 0.0004
398 HIP SURGERY 2 0.0004
399 PRODUCT TASTE ABNORMAL 5 0.0004
400 FOOT FRACTURE 7 0.0004
401 BIPOLAR DISORDER 4 0.0004
402 INTENTIONAL PRODUCT MISUSE 32 0.0004
403 NONSPECIFIC REACTION 2 0.0004
404 ACUTE RESPIRATORY FAILURE 7 0.0004
405 CONDITION AGGRAVATED 110 0.0004
406 CYSTIC FIBROSIS 2 0.0004
407 PNEUMONIA ASPIRATION 9 0.0004
408 HEART RATE ABNORMAL 2 0.0004
409 TOXICITY TO VARIOUS AGENTS 60 0.0004
410 EYE INFECTION 4 0.0004
411 DISABILITY 7 0.0004
412 PREMATURE LABOUR 2 0.0004
413 ABNORMAL BEHAVIOUR 14 0.0004
414 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 6 0.0004
415 CIRCULATORY COLLAPSE 6 0.0004
416 BONE DENSITY DECREASED 11 0.0004
417 PARANOIA 6 0.0003
418 CARDIAC MURMUR 3 0.0003
419 RHEUMATOID FACTOR POSITIVE 2 0.0003
420 SOCIAL AVOIDANT BEHAVIOUR 2 0.0003
421 SKIN SWELLING 3 0.0003
422 NERVOUSNESS 18 0.0003
423 DISCOMFORT 21 0.0003
424 NIGHT SWEATS 11 0.0003
425 HEADACHE 214 0.0003
426 COLD SWEAT 6 0.0003
427 URINE ODOUR ABNORMAL 2 0.0003
428 SOMNOLENCE 68 0.0003
429 SINUS HEADACHE 2 0.0003
430 WRIST FRACTURE 4 0.0003
431 GASTROENTERITIS VIRAL 6 0.0003
432 LUPUS-LIKE SYNDROME 3 0.0003
433 LETHARGY 19 0.0003
434 ADRENAL INSUFFICIENCY 4 0.0003
435 OVERDOSE 71 0.0003
436 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 2 0.0003
437 TENSION 2 0.0003
438 RETCHING 7 0.0003
439 NEPHROLITHIASIS 15 0.0003
440 IRRITABLE BOWEL SYNDROME 7 0.0003
441 BLOOD THYROID STIMULATING HORMONE INCREASED 3 0.0003
442 MENISCUS INJURY 2 0.0003
443 NERVE COMPRESSION 3 0.0003
444 EMOTIONAL DISORDER 10 0.0003
445 OROPHARYNGEAL PAIN 30 0.0003
446 CONCOMITANT DISEASE AGGRAVATED 2 0.0003
447 TENDONITIS 5 0.0003
448 DERMATITIS ATOPIC 17 0.0003
449 LACERATION 3 0.0003
450 PRODUCT USE COMPLAINT 5 0.0003
451 UNEVALUABLE EVENT 24 0.0003
452 PRODUCTIVE COUGH 15 0.0003
453 LOWER LIMB FRACTURE 6 0.0003
454 SINUSITIS 32 0.0003
455 THERAPEUTIC RESPONSE UNEXPECTED 14 0.0003
456 C-REACTIVE PROTEIN ABNORMAL 2 0.0003
457 HAEMOGLOBIN ABNORMAL 2 0.0003
458 ROAD TRAFFIC ACCIDENT 13 0.0003
459 ATELECTASIS 3 0.0003
460 SINUS BRADYCARDIA 3 0.0003
461 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 17 0.0003
462 HYPERPROLACTINAEMIA 2 0.0003
463 DRY MOUTH 25 0.0003
464 PRODUCT AVAILABILITY ISSUE 7 0.0003
465 URINARY INCONTINENCE 9 0.0003
466 IMMUNE SYSTEM DISORDER 4 0.0003
467 LIGAMENT SPRAIN 3 0.0003
468 BLADDER DISORDER 3 0.0003
469 DRUG INEFFECTIVE 396 0.0003
470 SPINAL FRACTURE 6 0.0003
471 HAIR TEXTURE ABNORMAL 4 0.0003
472 MENTAL DISORDER 13 0.0003
473 MEMORY IMPAIRMENT 41 0.0003
474 APHASIA 9 0.0003
475 FLUID RETENTION 15 0.0003
476 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 2 0.0003
477 SLUGGISHNESS 3 0.0003
478 ABNORMAL LOSS OF WEIGHT 2 0.0003
479 TACHYCARDIA 26 0.0003
480 PRODUCT DOSE OMISSION ISSUE 86 0.0003
481 EAR DISCOMFORT 3 0.0003
482 ASTHMA 33 0.0003
483 ECCHYMOSIS 2 0.0003
484 ONYCHOCLASIS 2 0.0003
485 RESPIRATION ABNORMAL 2 0.0003
486 THROAT IRRITATION 13 0.0003
487 DROOLING 2 0.0003
488 BALANCE DISORDER 25 0.0003
489 WEIGHT FLUCTUATION 3 0.0003
490 NECK PAIN 16 0.0003
491 ABDOMINAL DISCOMFORT 48 0.0003
492 DEFAECATION URGENCY 2 0.0003
493 HEAD INJURY 9 0.0003
494 EATING DISORDER 6 0.0003
495 BODY HEIGHT DECREASED 3 0.0003
496 HEREDITARY ANGIOEDEMA 3 0.0003
497 PELVIC PAIN 5 0.0003
498 DYSSTASIA 8 0.0003
499 DIZZINESS 135 0.0003
500 DYSKINESIA 11 0.0003
501 VENTRICULAR FIBRILLATION 3 0.0003
502 ALOPECIA 53 0.0003
503 NERVE INJURY 3 0.0003
504 THERAPEUTIC PRODUCT EFFECT DECREASED 12 0.0003
505 SEDATION 7 0.0003
506 HYDRONEPHROSIS 2 0.0003
507 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 19 0.0003
508 BLOOD SODIUM DECREASED 5 0.0003
509 DERMATITIS CONTACT 3 0.0003
510 NAUSEA 208 0.0003
511 MICTURITION URGENCY 3 0.0003
512 VISION BLURRED 36 0.0003
513 ACIDOSIS 2 0.0003
514 DISSOCIATION 2 0.0003
515 THYROID DISORDER 4 0.0003
516 LIMB INJURY 7 0.0003
517 EXPOSURE DURING PREGNANCY 16 0.0003
518 HYPOALBUMINAEMIA 2 0.0003
519 EAR PAIN 5 0.0003
520 PELVIC FRACTURE 2 0.0003
521 ORAL HERPES 5 0.0003
522 SPINAL PAIN 3 0.0003
523 HYPOACUSIS 11 0.0003
524 PRODUCT USE ISSUE 48 0.0003
525 DISORIENTATION 10 0.0003
526 HALLUCINATION, AUDITORY 4 0.0003
527 BLOOD PRESSURE ABNORMAL 5 0.0003
528 GINGIVAL PAIN 2 0.0003
529 OBESITY 4 0.0003
530 HYPERLIPIDAEMIA 3 0.0003
531 SCIATICA 4 0.0003
532 METABOLIC ACIDOSIS 8 0.0002
533 WEIGHT INCREASED 56 0.0002
534 HEPATIC ENZYME INCREASED 17 0.0002
535 PRESYNCOPE 6 0.0002
536 DECUBITUS ULCER 2 0.0002
537 PSORIASIS 32 0.0002
538 WEIGHT DECREASED 68 0.0002
539 MULTIPLE FRACTURES 4 0.0002
540 OSTEOPOROSIS 10 0.0002
541 HYPERSENSITIVITY 45 0.0002
542 GENERALISED OEDEMA 3 0.0002
543 DYSGEUSIA 18 0.0002
544 HEART RATE INCREASED 24 0.0002
545 DRUG LEVEL INCREASED 4 0.0002
546 MENSTRUAL DISORDER 2 0.0002
547 TOOTH LOSS 5 0.0002
548 HAIR COLOUR CHANGES 3 0.0002
549 AGEUSIA 6 0.0002
550 NEEDLE ISSUE 7 0.0002
551 ADVERSE EVENT 22 0.0002
552 FATIGUE 185 0.0002
553 TREATMENT NONCOMPLIANCE 13 0.0002
554 SENSATION OF FOREIGN BODY 2 0.0002
555 MUSCLE ATROPHY 3 0.0002
556 CATARACT 14 0.0002
557 HYPOPHAGIA 6 0.0002
558 URINARY TRACT INFECTION 40 0.0002
559 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 4 0.0002
560 PRODUCT CONTAINER ISSUE 2 0.0002
561 INFLUENZA 26 0.0002
562 CARDIAC OPERATION 2 0.0002
563 ABNORMAL SENSATION IN EYE 1 0.0002
564 EXPOSURE VIA SKIN CONTACT 6 0.0002
565 MUSCLE STRAIN 2 0.0002
566 RASH ERYTHEMATOUS 11 0.0002
567 ORAL CANDIDIASIS 3 0.0002
568 TOOTH INFECTION 3 0.0002
569 GRIP STRENGTH DECREASED 2 0.0002
570 INFUSION RELATED REACTION 15 0.0002
571 DYSMENORRHOEA 3 0.0002
572 TOOTH DISORDER 5 0.0002
573 EYE HAEMORRHAGE 3 0.0002
574 CONSTIPATION 49 0.0002
575 MENSTRUATION IRREGULAR 6 0.0002
576 QUALITY OF LIFE DECREASED 3 0.0002
577 GLOSSODYNIA 5 0.0002
578 PSORIATIC ARTHROPATHY 9 0.0002
579 DEVICE BREAKAGE 9 0.0002
580 OSTEOMYELITIS 4 0.0002
581 HIDRADENITIS 2 0.0002
582 IRON DEFICIENCY ANAEMIA 2 0.0002
583 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
584 ORAL DISCOMFORT 3 0.0002
585 CONJUNCTIVITIS 4 0.0002
586 URTICARIA 36 0.0002
587 HEPATIC STEATOSIS 4 0.0002
588 PRODUCT DOSE OMISSION 14 0.0002
589 NEPHROPATHY 2 0.0002
590 INFECTION 31 0.0002
591 COGNITIVE DISORDER 10 0.0002
592 VERTIGO 13 0.0002
593 HYPERTENSION 45 0.0002
594 FLATULENCE 12 0.0002
595 THERAPEUTIC RESPONSE SHORTENED 7 0.0002
596 POISONING DELIBERATE 2 0.0002
597 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 11 0.0002
598 BLOOD PRESSURE DECREASED 14 0.0002
599 CHRONIC KIDNEY DISEASE 16 0.0002
600 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
601 POST PROCEDURAL COMPLICATION 4 0.0002
602 DECREASED APPETITE 48 0.0002
603 EMOTIONAL DISTRESS 25 0.0002
604 FIBROMYALGIA 5 0.0002
605 NEURALGIA 5 0.0002
606 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 37 0.0002
607 PARKINSONISM 2 0.0002
608 CONFUSIONAL STATE 33 0.0002
609 ABDOMINAL PAIN UPPER 42 0.0002
610 VITREOUS FLOATERS 2 0.0002
611 DRUG INTERACTION 32 0.0002
612 OVARIAN CYST 2 0.0002
613 AMNESIA 13 0.0002
614 COUGH 56 0.0002
615 HEART RATE DECREASED 7 0.0002
616 PAIN 122 0.0002
617 INTENTIONAL SELF-INJURY 4 0.0002
618 BLOOD COUNT ABNORMAL 3 0.0002
619 ABDOMINAL PAIN LOWER 5 0.0002
620 VAGINAL DISCHARGE 2 0.0002
621 EXTRA DOSE ADMINISTERED 8 0.0002
622 TASTE DISORDER 4 0.0002
623 TOOTH ABSCESS 2 0.0002
624 BODY TEMPERATURE INCREASED 4 0.0002
625 HIP ARTHROPLASTY 3 0.0002
626 VOMITING 92 0.0002
627 TEMPERATURE INTOLERANCE 2 0.0002
628 ANKLE FRACTURE 3 0.0002
629 MUSCULAR WEAKNESS 22 0.0002
630 POOR VENOUS ACCESS 2 0.0002
631 DELUSION 3 0.0002
632 BLOOD CHOLESTEROL INCREASED 9 0.0002
633 EYE DISCHARGE 2 0.0002
634 PULMONARY HYPERTENSION 4 0.0002
635 RESPIRATORY TRACT INFECTION 5 0.0002
636 TENDERNESS 2 0.0002
637 ABDOMINAL DISTENSION 20 0.0002
638 DEAFNESS 5 0.0002
639 CYANOSIS 3 0.0002
640 RESPIRATORY TRACT CONGESTION 3 0.0002
641 PALPITATIONS 22 0.0002
642 JOINT INJURY 4 0.0002
643 EPISTAXIS 14 0.0002
644 MALAISE 82 0.0002
645 FALL 62 0.0002
646 ASTHENIA 70 0.0002
647 HOT FLUSH 14 0.0002
648 RHINORRHOEA 12 0.0002
649 FREQUENT BOWEL MOVEMENTS 5 0.0002
650 ALTERED STATE OF CONSCIOUSNESS 4 0.0002
651 SKIN LACERATION 2 0.0002
652 PRODUCT DISPENSING ERROR 4 0.0002
653 PULMONARY THROMBOSIS 2 0.0002
654 WOUND INFECTION 2 0.0002
655 ASPIRATION 2 0.0002
656 DRUG WITHDRAWAL SYNDROME 16 0.0002
657 GASTROINTESTINAL PAIN 2 0.0002
658 TOOTH FRACTURE 2 0.0002
659 FOOT DEFORMITY 2 0.0002
660 VIRAL INFECTION 6 0.0002
661 PROCEDURAL PAIN 5 0.0002
662 AGGRESSION 9 0.0002
663 HYPERTENSIVE CRISIS 2 0.0002
664 FEELING COLD 5 0.0002
665 HYPOTENSION 36 0.0002
666 WOUND 5 0.0002
667 SKIN INFECTION 2 0.0002
668 OXYGEN SATURATION DECREASED 10 0.0002
669 CANDIDA INFECTION 3 0.0002
670 GAIT DISTURBANCE 34 0.0002
671 VISUAL IMPAIRMENT 22 0.0002
672 DEPRESSED LEVEL OF CONSCIOUSNESS 7 0.0002
673 BLOOD PRESSURE INCREASED 27 0.0002
674 DRUG INTOLERANCE 17 0.0002
675 BRONCHITIS 13 0.0002
676 SCAB 2 0.0002
677 CHOLECYSTECTOMY 2 0.0002
678 HERPES ZOSTER 10 0.0002
679 SHOCK 4 0.0002
680 PNEUMONIA 56 0.0002
681 DYSPEPSIA 17 0.0002
682 HALLUCINATION 13 0.0002
683 EYELID OEDEMA 2 0.0002
684 BLINDNESS 7 0.0002
685 PARAESTHESIA 27 0.0002
686 NEUROTOXICITY 3 0.0002
687 BURNING SENSATION 12 0.0002
688 SEXUAL DYSFUNCTION 2 0.0002
689 ASCITES 5 0.0002
690 LYMPHOCYTE COUNT DECREASED 3 0.0002
691 LYMPHADENOPATHY 6 0.0002
692 HEAD DISCOMFORT 3 0.0002
693 DRUG ERUPTION 3 0.0002
694 TREATMENT FAILURE 14 0.0002
695 THIRST 3 0.0002
696 POLLAKIURIA 7 0.0002
697 MACULAR DEGENERATION 2 0.0002
698 MULTIPLE SCLEROSIS 8 0.0002
699 DRUG EFFECT DECREASED 9 0.0002
700 BLOOD POTASSIUM DECREASED 5 0.0002
701 OEDEMA 9 0.0002
702 TOOTHACHE 3 0.0002
703 LACRIMATION INCREASED 5 0.0002
704 ARTHRITIS 13 0.0002
705 DEHYDRATION 22 0.0002
706 ACCIDENTAL OVERDOSE 6 0.0002
707 MUSCLE SPASMS 30 0.0002
708 CYTOPENIA 2 0.0002
709 DYSURIA 6 0.0002
710 SMALL INTESTINAL OBSTRUCTION 2 0.0002
711 PHARYNGITIS 2 0.0002
712 DIARRHOEA 104 0.0002
713 OFF LABEL USE 141 0.0002
714 DEVICE DISLOCATION 7 0.0002
715 DRY EYE 8 0.0002
716 DYSARTHRIA 6 0.0002
717 BACK PAIN 37 0.0002
718 DERMATITIS ALLERGIC 2 0.0002
719 BRAIN OEDEMA 2 0.0002
720 BLOOD URINE PRESENT 3 0.0002
721 PRODUCT COMPLAINT 4 0.0002
722 MUSCULOSKELETAL DISORDER 3 0.0002
723 JOINT SWELLING 19 0.0002
724 INCREASED APPETITE 3 0.0002
725 HYPOTHYROIDISM 5 0.0002
726 WHITE BLOOD CELL COUNT INCREASED 6 0.0002
727 HEPATITIS 4 0.0002
728 PULMONARY OEDEMA 7 0.0002
729 DRUG ABUSE 13 0.0002
730 PRURITUS 60 0.0002
731 THERAPY CESSATION 8 0.0002
732 ERECTILE DYSFUNCTION 4 0.0002
733 HERNIA 3 0.0002
734 DYSTONIA 3 0.0002
735 DIPLOPIA 4 0.0002
736 NASAL CONGESTION 9 0.0002
737 APPLICATION SITE ERYTHEMA 4 0.0002
738 JOINT STIFFNESS 4 0.0002
739 GASTRITIS 4 0.0002
740 NASOPHARYNGITIS 28 0.0002
741 ANKYLOSING SPONDYLITIS 2 0.0002
742 PULMONARY CONGESTION 2 0.0002
743 ACTIVITIES OF DAILY LIVING IMPAIRED 3 0.0002
744 BRADYCARDIA 8 0.0002
745 UPPER LIMB FRACTURE 3 0.0002
746 EXPIRED PRODUCT ADMINISTERED 5 0.0002
747 PRODUCT USE IN UNAPPROVED INDICATION 37 0.0001
748 MALIGNANT MELANOMA 2 0.0001
749 JOINT RANGE OF MOTION DECREASED 2 0.0001
750 GASTROOESOPHAGEAL REFLUX DISEASE 12 0.0001
751 FEAR 4 0.0001
752 TYPE 2 DIABETES MELLITUS 5 0.0001
753 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 30 0.0001
754 WHITE BLOOD CELL COUNT DECREASED 16 0.0001
755 HYPOAESTHESIA 22 0.0001
756 FEELING HOT 9 0.0001
757 AKATHISIA 2 0.0001
758 GASTRIC DISORDER 5 0.0001
759 CONTUSION 14 0.0001
760 DELIRIUM 5 0.0001
761 NEOPLASM PROGRESSION 5 0.0001
762 COORDINATION ABNORMAL 2 0.0001
763 CARPAL TUNNEL SYNDROME 2 0.0001
764 RASH 62 0.0001
765 MYALGIA 24 0.0001
766 THERAPY INTERRUPTED 10 0.0001
767 LIVER FUNCTION TEST INCREASED 3 0.0001
768 PARALYSIS 2 0.0001
769 SKIN CANCER 3 0.0001
770 FAECES DISCOLOURED 3 0.0001
771 ANOSMIA 2 0.0001
772 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
773 PRODUCT PRESCRIBING ISSUE 3 0.0001
774 CLOSTRIDIUM DIFFICILE INFECTION 3 0.0001
775 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
776 ARTHRALGIA 57 0.0001
777 CARDIAC FAILURE CONGESTIVE 11 0.0001
778 BONE PAIN 8 0.0001
779 APPLICATION SITE PAIN 3 0.0001
780 LABORATORY TEST ABNORMAL 4 0.0001
781 SKIN HAEMORRHAGE 2 0.0001
782 ORAL PAIN 3 0.0001
783 ECZEMA 7 0.0001
784 HAEMORRHAGE INTRACRANIAL 2 0.0001
785 SPEECH DISORDER 7 0.0001
786 BONE LOSS 2 0.0001
787 HEART RATE IRREGULAR 3 0.0001
788 DYSPNOEA EXERTIONAL 5 0.0001
789 HYPOAESTHESIA ORAL 2 0.0001
790 DEVICE FAILURE 2 0.0001
791 SKIN DISCOLOURATION 6 0.0001
792 INJECTION SITE RASH 4 0.0001
793 MUSCLE TWITCHING 3 0.0001
794 SYNCOPE 13 0.0001
795 PERICARDIAL EFFUSION 3 0.0001
796 LIMB DISCOMFORT 4 0.0001
797 NERVOUS SYSTEM DISORDER 4 0.0001
798 SWOLLEN TONGUE 4 0.0001
799 INJURY 9 0.0001
800 CHEST DISCOMFORT 13 0.0001
801 ARRHYTHMIA 6 0.0001
802 DYSPHAGIA 12 0.0001
803 ACCIDENTAL EXPOSURE TO PRODUCT 13 0.0001
804 PRODUCT PRESCRIBING ERROR 3 0.0001
805 ARTHROPATHY 7 0.0001
806 PREMATURE DELIVERY 2 0.0001
807 MUSCULOSKELETAL STIFFNESS 11 0.0001
808 BLOOD PRESSURE FLUCTUATION 3 0.0001
809 BLOOD GLUCOSE DECREASED 6 0.0001
810 SENSORY DISTURBANCE 2 0.0001
811 EYE PAIN 7 0.0001
812 MENTAL IMPAIRMENT 3 0.0001
813 MUSCLE TIGHTNESS 2 0.0001
814 RHEUMATOID ARTHRITIS 14 0.0001
815 BLOOD POTASSIUM INCREASED 2 0.0001
816 CHOLELITHIASIS 4 0.0001
817 PHOTOSENSITIVITY REACTION 2 0.0001
818 ACUTE CORONARY SYNDROME 1 0.0001
819 LIP SWELLING 4 0.0001
820 SKIN DISORDER 4 0.0001
821 DYSPHONIA 7 0.0001
822 BLOOD UREA INCREASED 2 0.0001
823 EYE PRURITUS 4 0.0001
824 RENAL IMPAIRMENT 10 0.0001
825 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
826 SKIN EXFOLIATION 10 0.0001
827 DYSPNOEA 67 0.0001
828 HAEMATEMESIS 3 0.0001
829 OSTEOARTHRITIS 5 0.0001
830 SWELLING 11 0.0001
831 LOSS OF CONSCIOUSNESS 15 0.0001
832 PERIPHERAL SWELLING 18 0.0001
833 NO ADVERSE EVENT 21 0.0001
834 DEVICE LEAKAGE 5 0.0001
835 ILL-DEFINED DISORDER 7 0.0001
836 VAGINAL HAEMORRHAGE 5 0.0001
837 RASH MACULAR 4 0.0001
838 HYPOXIA 4 0.0001
839 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
840 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
841 LIVER DISORDER 5 0.0001
842 SYSTEMIC LUPUS ERYTHEMATOSUS 4 0.0001
843 ERYTHEMA 23 0.0001
844 GASTROINTESTINAL DISORDER 10 0.0001
845 SYNOVITIS 2 0.0001
846 RASH PRURITIC 6 0.0001
847 LOWER RESPIRATORY TRACT INFECTION 5 0.0001
848 BONE DISORDER 2 0.0001
849 RESPIRATORY FAILURE 8 0.0001
850 SKIN LESION 3 0.0001
851 INFLUENZA LIKE ILLNESS 9 0.0001
852 SKIN IRRITATION 5 0.0001
853 ANAPHYLACTIC REACTION 6 0.0001
854 DIVERTICULITIS 3 0.0001
855 HAEMOPTYSIS 3 0.0001
856 SWELLING FACE 7 0.0001
857 HEPATIC CIRRHOSIS 2 0.0001
858 TARDIVE DYSKINESIA 3 0.0001
859 ABORTION INDUCED 1 0.0001
860 INTESTINAL OBSTRUCTION 4 0.0001
861 FRACTURE 2 0.0001
862 INCORRECT DOSE ADMINISTERED 24 0.0001
863 EYE IRRITATION 6 0.0001
864 DRUG PRESCRIBING ERROR 2 0.0001
865 KIDNEY INFECTION 2 0.0001
866 ACUTE MYOCARDIAL INFARCTION 3 0.0001
867 SINUS DISORDER 2 0.0001
868 HAEMATOCRIT DECREASED 2 0.0001
869 RESPIRATORY DISORDER 3 0.0001
870 INJECTION SITE BRUISING 8 0.0001
871 PRESCRIBED UNDERDOSE 2 0.0001
872 PREMATURE BABY 3 0.0001
873 DEVICE MALFUNCTION 7 0.0001
874 FULL BLOOD COUNT DECREASED 2 0.0001
875 PRODUCT ADMINISTRATION ERROR 2 0.0001
876 SEPSIS 11 0.0001
877 PYREXIA 34 0.0001
878 ACUTE KIDNEY INJURY 15 0.0001
879 RENAL FAILURE 13 0.0001
880 HOSPITALISATION 15 0.0001
881 MOBILITY DECREASED 7 0.0001
882 DRY SKIN 13 0.0001
883 PRODUCT PREPARATION ERROR 2 0.0001
884 INJECTION SITE WARMTH 2 0.0001
885 CARDIAC DISORDER 9 0.0001
886 UNDERDOSE 7 0.0001
887 DERMATITIS 2 0.0001
888 PAIN IN EXTREMITY 28 0.0001
889 NEUROPATHY PERIPHERAL 9 0.0001
890 CHILLS 11 0.0001
891 HIP FRACTURE 3 0.0001
892 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
893 FUNGAL INFECTION 3 0.0001
894 TRANSAMINASES INCREASED 2 0.0001
895 URINARY RETENTION 3 0.0001
896 RASH MACULO-PAPULAR 2 0.0001
897 GAIT INABILITY 3 0.0001
898 RASH PAPULAR 2 0.0001
899 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
900 CHROMATURIA 2 0.0001
901 FLUSHING 9 0.0001
902 INJECTION SITE REACTION 6 0.0001
903 CARDIAC FAILURE 7 0.0001
904 GENERAL PHYSICAL HEALTH DETERIORATION 10 0.0001
905 FOETAL EXPOSURE DURING PREGNANCY 7 0.0001
906 RENAL DISORDER 4 0.0001
907 WHEEZING 5 0.0001
908 COMA 4 0.0001
909 PRODUCT ADHESION ISSUE 3 0.0001
910 ACCIDENT 1 0.0001
911 HEPATIC CANCER 2 0.0001
912 LOCALISED INFECTION 2 0.0001
913 THERAPEUTIC RESPONSE DECREASED 5 0.0001
914 PLEURAL EFFUSION 5 0.0001
915 CHEST PAIN 15 0.0001
916 ABNORMAL WEIGHT GAIN 1 0.0001
917 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
918 COLITIS 3 0.0001
919 INJECTION SITE SWELLING 6 0.0001
920 INFLAMMATION 4 0.0001
921 HAEMATOMA 2 0.0001
922 INJECTION SITE HAEMORRHAGE 6 0.0001
923 BREAST CANCER 7 0.0001
924 PLATELET COUNT DECREASED 8 0.0001
925 THROAT TIGHTNESS 2 0.0001
926 NEUTROPHIL COUNT DECREASED 3 0.0001
927 ANAEMIA 14 0.0001
928 ACUTE HEPATIC FAILURE 1 0.0001
929 ABDOMINAL PAIN 17 0.0001
930 RESPIRATORY ARREST 2 0.0001
931 INJECTION SITE ERYTHEMA 9 0.0001
932 RHABDOMYOLYSIS 3 0.0001
933 DEMENTIA 2 0.0001
934 THROMBOCYTOPENIA 8 0.0001
935 BLISTER 4 0.0001
936 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2 0.0001
937 PAIN IN JAW 2 0.0001
938 RED BLOOD CELL COUNT DECREASED 2 0.0001
939 SEPTIC SHOCK 3 0.0001
940 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
941 MATERNAL EXPOSURE DURING PREGNANCY 6 0.0001
942 DIABETES MELLITUS 5 0.0001
943 EPILEPSY 2 0.0001
944 INJECTION SITE PAIN 20 0.0001
945 CEREBROVASCULAR ACCIDENT 11 0.0001
946 FEMUR FRACTURE 2 0.0001
947 DRUG-INDUCED LIVER INJURY 2 0.0001
948 CYSTITIS 2 0.0001
949 HYPOGLYCAEMIA 3 0.0001
950 ATRIAL FIBRILLATION 6 0.0001
951 BLOOD CREATININE INCREASED 4 0.0001
952 OSTEONECROSIS 2 0.0001
953 INJECTION SITE PRURITUS 4 0.0001
954 MULTIPLE SCLEROSIS RELAPSE 4 0.0001
955 MUSCULOSKELETAL PAIN 3 0.0001
956 CEREBRAL HAEMORRHAGE 2 0.0001
957 DEVICE ISSUE 5 0.0001
958 INJECTION SITE MASS 2 0.0001
959 EYE SWELLING 2 0.0001
960 HYPONATRAEMIA 3 0.0001
961 BLOOD GLUCOSE INCREASED 10 0.0001
962 ACNE 4 0.0001
963 ABORTION SPONTANEOUS 2 0.0000
964 DRUG DEPENDENCE 8 0.0000
965 THROMBOSIS 4 0.0000
966 DRUG DOSE OMISSION 8 0.0000
967 DEEP VEIN THROMBOSIS 3 0.0000
968 MYOCARDIAL INFARCTION 8 0.0000
969 PRODUCT STORAGE ERROR 4 0.0000
970 ANGIOEDEMA 2 0.0000
971 COLITIS ULCERATIVE 2 0.0000
972 HYPOKALAEMIA 2 0.0000
973 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 2 0.0000
974 DISEASE PROGRESSION 5 0.0000
975 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 3 0.0000
976 OCULAR HYPERAEMIA 2 0.0000
977 PULMONARY EMBOLISM 4 0.0000
978 LUNG DISORDER 2 0.0000
979 DEATH 34 0.0000
980 PANCREATITIS 2 0.0000
981 HAEMATOCHEZIA 2 0.0000
982 MEDICATION ERROR 2 0.0000
983 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
984 DEVICE EXPULSION 2 0.0000
985 HAEMOGLOBIN DECREASED 3 0.0000
986 HAEMORRHAGE 3 0.0000
987 DRUG DOSE OMISSION BY DEVICE 2 0.0000
988 OEDEMA PERIPHERAL 3 0.0000
989 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
990 NEUTROPENIA 2 0.0000